Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) Current Cash

Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) (EUCRU) currently reports a current cash of $19K as of December 2022. That compares with $49K in the prior-year period — down 61.6% year over year. Use the charts on this page to explore Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s current cash history and peer comparisons.

Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s current cash decreased from $49K to $19K — a 61.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) reported $19K in current cash as of December 2022. That compares with $49K in the prior-year period — down 61.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $19K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War), and consider following EUCRU for alerts when major investors trade the stock.